Roche test Actemra in coronavirus patients as firms re-purpose drugs

Roche will test its arthritis drug Actemra in patients with coronavirus-linked pneumonia, the Swiss drugmaker said on Thursday, joining other pharmaceutical companies seeking to re-purpose existing medicines to fight the epidemic.